HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kiril Trpkov Selected Research

Leiomyomatosis

1/2021New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia.
4/2019Fumarate hydratase deficient renal cell carcinoma: Chromosomal numerical aberration analysis of 12 cases.
1/2019Fumarate hydratase deficient renal cell carcinoma and fumarate hydratase deficient-like renal cell carcinoma: Morphologic comparative study of 23 genetically tested cases.
1/2018Reappraisal of Morphologic Differences Between Renal Medullary Carcinoma, Collecting Duct Carcinoma, and Fumarate Hydratase-deficient Renal Cell Carcinoma.
1/2018SWI/SNF protein expression status in fumarate hydratase-deficient renal cell carcinoma: immunohistochemical analysis of 32 tumors from 28 patients.
11/2016Tubulocystic Carcinoma of the Kidney With Poorly Differentiated Foci: A Frequent Morphologic Pattern of Fumarate Hydratase-deficient Renal Cell Carcinoma.
5/2016Fumarate Hydratase-deficient Uterine Leiomyomas Occur in Both the Syndromic and Sporadic Settings.
1/2016Fumarate Hydratase-deficient Renal Cell Carcinoma Is Strongly Correlated With Fumarate Hydratase Mutation and Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kiril Trpkov Research Topics

Disease

43Neoplasms (Cancer)
05/2022 - 12/2007
22Renal Cell Carcinoma (Grawitz Tumor)
05/2022 - 11/2014
19Prostatic Neoplasms (Prostate Cancer)
12/2020 - 01/2003
10Carcinoma (Carcinomatosis)
01/2022 - 03/2010
8Leiomyomatosis
01/2021 - 01/2016
4Adenocarcinoma
09/2020 - 03/2015
4Tuberous Sclerosis (Bourneville's Disease)
01/2020 - 11/2014
4Disease Progression
11/2014 - 10/2009
3Prostatic Intraepithelial Neoplasia
01/2021 - 06/2011
3Infections
06/2016 - 03/2010
3Fibrosis (Cirrhosis)
02/2013 - 02/2007
2Oxyphilic Adenoma (Oncocytoma)
05/2022 - 01/2017
2Necrosis
01/2022 - 01/2021
2Neoplasm Metastasis (Metastasis)
01/2021 - 09/2019
2Metaplasia
09/2020 - 01/2018
2Margins of Excision
01/2019 - 10/2008
2Medullary Carcinoma
01/2018 - 01/2018
2Leiomyoma (Uterine Fibroids)
05/2016 - 03/2015
2Kidney Diseases (Kidney Disease)
04/2016 - 10/2010
2Angiomyolipoma
03/2015 - 11/2014
2Inflammation (Inflammations)
02/2013 - 10/2010
1Carcinoma in Situ
01/2022
1Noninfiltrating Intraductal Carcinoma (DCIS)
01/2021
1Villous Adenoma
09/2020
1Monosomy
01/2020
1Hemoglobinopathies
01/2018
1Malacoplakia
06/2016
1Chronic Kidney Failure (Chronic Renal Failure)
04/2016
1Kidney Neoplasms (Kidney Cancer)
01/2016
1Testicular Neoplasms (Testicular Cancer)
09/2015
1Xanthomatosis (Xanthoma)
08/2015
1Cysts
03/2015
1Melanosis (Freckles)
10/2013
1Flatulence
06/2011
1Glomerulonephritis
02/2011

Drug/Important Bio-Agent (IBA)

12Fumarate Hydratase (Fumarase)IBA
01/2021 - 01/2016
9trans-sodium crocetinate (crocetin)IBA
05/2022 - 11/2014
5Succinate Dehydrogenase (Fumarate Reductase)IBA
01/2022 - 12/2014
4Biological ProductsIBA
01/2022 - 03/2010
4Biomarkers (Surrogate Marker)IBA
01/2022 - 03/2011
3Keratin-7 (Cytokeratin 7)IBA
05/2022 - 03/2015
3Anaplastic Lymphoma KinaseIBA
01/2021 - 01/2019
3Messenger RNA (mRNA)IBA
08/2017 - 10/2010
3Prostate-Specific Antigen (Semenogelase)IBA
03/2015 - 06/2006
2Capsules (Microcapsules)IBA
01/2022 - 03/2015
2VimentinIBA
01/2022 - 08/2018
2Phenobarbital (Luminal)FDA Link
01/2021 - 01/2021
2GP 4 (GP4)IBA
01/2021 - 10/2015
2Cathepsin KIBA
02/2020 - 03/2015
2Proteins (Proteins, Gene)FDA Link
01/2018 - 08/2013
2ParaffinIBA
08/2017 - 05/2016
2Formaldehyde (Formol)FDA Link
08/2017 - 05/2016
2NLR ProteinsIBA
04/2016 - 02/2013
2LipidsIBA
08/2015 - 03/2015
1Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)IBA
01/2022
1Hematoxylin (Haematoxylon)IBA
01/2022
1Eosine Yellowish-(YS) (Eosin)IBA
01/2022
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
07/2021
1Dexamethasone (Maxidex)FDA LinkGeneric
07/2021
1Bortezomib (Velcade)FDA Link
07/2021
1MucinsIBA
01/2021
1Technetium Tc 99m Sestamibi (Cardiolite)FDA LinkGeneric
12/2020
1raf KinasesIBA
12/2020
1Colloids (Colloid)IBA
09/2020
1AndrogensIBA
05/2020
1TensinsIBA
05/2020
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
05/2020
1IronIBA
02/2020
1RNA (Ribonucleic Acid)IBA
12/2018
1AntigensIBA
12/2018
1Sucrose (Saccharose)IBA
01/2018
1chenodeoxycholate sulfate conjugate (CDCS)IBA
01/2018
1LigandsIBA
08/2017
1Keratins (Keratin)IBA
01/2017
1CreatinineIBA
04/2016
1PyrinIBA
04/2016
1DesminIBA
03/2015
1Acid PhosphataseIBA
03/2015
1Melanins (Melanin)IBA
10/2013
1Vitamin EFDA LinkGeneric
06/2011
1SeleniumIBA
06/2011
1Testosterone (Sustanon)FDA Link
06/2011
1MicronutrientsIBA
06/2011
1Antigen-Antibody Complex (Immune Complex)IBA
02/2011
1Immunoglobulin A (IgA)IBA
02/2011

Therapy/Procedure

17Prostatectomy (Retropubic Prostatectomy)
01/2020 - 01/2003
3Radiotherapy
07/2021 - 10/2009
3Therapeutics
01/2021 - 01/2010
2Drug Therapy (Chemotherapy)
07/2021 - 01/2021
2Transurethral Resection of Prostate (TURP)
01/2019 - 08/2008
2Neoadjuvant Therapy
11/2018 - 08/2010
2Orchiectomy (Orchidectomy)
09/2015 - 08/2011
2Cryosurgery
01/2010 - 10/2009
1Immunotherapy
01/2021
1Contraindications
01/2020
1Lymph Node Excision (Lymph Node Dissection)
09/2019
1Conservative Treatment
01/2019
1Cystectomy
11/2018
1Nephrectomy
03/2015
1Castration
08/2013